# Cranial Radiotherapy or Intensive Chemotherapy With Hematopoietic Stem Cell Rescue for Primary Central Nervous System Lymphoma in Young Patients

> **NCT00863460** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Institut Curie** · enrollment: 140 (actual)

## Conditions studied

- Primary Central Nervous System Lymphoma

## Interventions

- **RADIATION:** cranial radiotherapy
- **DRUG:** intensive chemotherapy and hematopoietic stem cell rescue
- **DRUG:** MTX based chemotherapy

## Key facts

- **NCT ID:** NCT00863460
- **Lead sponsor:** Institut Curie
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2008-10-03
- **Primary completion:** 2016-05-17
- **Final completion:** 2026-05
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2019-02-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00863460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00863460, "Cranial Radiotherapy or Intensive Chemotherapy With Hematopoietic Stem Cell Rescue for Primary Central Nervous System Lymphoma in Young Patients". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00863460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*